Medical robots are the remote operated machines used in medical science. They are used in different segments of healthcare. Medical robotics has provided more accuracy and perfection for the treatment. Different surgical procedures like cardiothoracic procedures, general surgical procedures, urological procedures and many more are conducted with the assistance of medical robots. Complex surgeries become easier and the success rate of treatment also increases with the use of this technology.
The key driving factor for the growth of the market is increasing demand for more accurate surgeries to leave no room for human errors and ensure precision. Besides increasing prevalence of diseases, lots of opportunities in the field of medical robotics, growing hospital investments in improving the technology and increasing funding for the medical robotics is also contributing to the growth of the market. Although, robotics surgeries and treatment is very expensive and high cost of maintenance can restrain the growth of the market.
Get a sample report at https://www.marketresearchfuture.com/sample_request/996 .
Key players in the Robotic Flight Simulator Surgery market:
The global robotic flight simulator surgery market is highly fragmented with the presence of many local players and international players. The main focus of these players is cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through collaborations and partnerships to expand their overall market share.
Intuitive Surgical (US), TransEnterix (US), Titan Medical (Canada), Virtualincision (US), AVRA (US) Hansen Medical (US), Free hand (UK), Corindus Vascular Robots (US), Interventional Systems (US).
Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.
May, 2017: Intuitive Surgical announced the launch of its new da Vinci X Surgical System received FDA clearance in the United States. This system provides surgeons and hospitals with access to of the advanced robotic-assisted surgery technology. The System enables the customers to add advanced capabilities. The system can be used for the procedures such as prostatectomy, partial nephrectomy, benign hysterectomy and sacrocolpopexy.
April, 21017: Intuitive Surgical da Vinci X Surgical System received CE Mark approval in Europe. The company will focus on developing and innovative technologies in the market outcomes-focused products and value-oriented solutions.
September, 2017: Intuitive Surgical FDA clearance for use of the da Vinci S and da Vinci Si Surgical Systems in benign, base of tongue resection procedures.
June, 2014: Intuitive Surgical received a CE Mark for its da Vinci Xi Surgical System. This will help the company to achieve milestone in Europe robotic surgery market. In April, the da Vinci Xi System received clearance from the U.S. Food and Drug Administration (FDA) and is now commercialized in the U.S.
Browse Complete Report at https://www.marketresearchfuture.com/reports/robotic-flight-simulator-surgery-market-996 .
Corindus Vascular Robotics
December, 2017: Corindus Vascular Robotics announced the first commercial installation of a CorPath GRX System outside of the U.S. Corindus Vascular Robotics purchased the system by the Apex Heart Institute in Ahmedabad, India.
December, 2017: Corindus Vascular Robotics announced that Houston Methodist DeBakey Heart & Vascular Center, a launched the first vascular robotic program in the Houston area with the installation of two CorPath GRX Systems. Additionally, Corindus will partner with Houston Methodist for the development of a Global Center of Excellence that will seek to advance clinical research on robotics and to train interventional cardiologists on robotic-assisted percutaneous coronary interventions (PCI).
March, 2017: Corindus Vascular Robotics announced the first robotic-assisted PCI procedures were performed in Asia using its CorPath GRX System.
iSYS 1 Technology, ands iFIX Technology are two major technologies offered by the company for robotic surgery. It also manufacturers various products such as iSYS 1 for Fluoroscopy, iSYS 1 for CT, and iFIX.
Titan Medical Inc.:
December, 2017: Titan Medical Inc. reported first use of its SPORT Surgical System in Europe, which was carried out in general and urologic surgery at the Institute of Image-Guided Surgery at the Institut Hospitalo-Universitaire de Strasbourg, France.
December, 2017: Titan Medical Inc. announced the grant of Canadian Patent CA 2973227 and CA 2973235. The patents are related generally to control methods for robotic surgical systems, including the provision of select autonomous control and safety functions that enable optimal controllability of robotic instruments during use.
September, 2017: Titan Medical Inc. announced the completion of the world’s first gynecologic, colorectal and urologic single port robotic procedures using advanced prototype SPORT Surgical System at the Florida Hospital Nicholson Center in Celebration, Florida.
More Inquire at https://www.marketresearchfuture.com/enquiry/996 .
The report for Global Robotic Flight Simulator Surgery Markets of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –